Share on LinkedInShare on LinkedIn

ARTICLE · 09 MAY 2024

U.S. Drug Enforcement Administration Recommends Rescheduling Marijuana To Schedule III, Similar To Tylenol With Codeine

Jackson Lewis P.C.
Jackson Lewis P.C.
Contributor
Jackson Lewis P.C.

Jackson Lewis P.C.

Focused on labor and employment law since 1958, Jackson Lewis P.C.’s 950+ attorneys located in...

View firm profile
Explore more from Jackson Lewis P.C.

The U.S. Drug Enforcement Administration will recommend that marijuana should be rescheduled from a Schedule I drug to a Schedule III drug, according to an announcement made April 30, 2024...

United StatesCannabis & Hemp

The U.S. Drug Enforcement Administration will recommend that marijuana should be rescheduled from a Schedule I drug to a Schedule III drug, according to an announcement made April 30, 2024 by the U.S. Department of Justice. This means that marijuana would be considered a drug with "moderate to low potential for physical and psychological dependence."

Under the federal Controlled Substances Act, the DEA classifies drugs into five distinct categories, or schedules, depending on the drug's acceptable medical use and its potential for abuse or dependence. Schedule I drugs have a high potential for abuse and the potential to create severe psychological and/or physical dependence. As the drug schedule changes, so does the abuse potential, with Schedule V representing the drugs with least potential for abuse.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from